Possible Role of Laxatives in Analgesic Nephropathy

Wainscoat, J. S.; Finn, Ronald
December 1974
British Medical Journal;12/21/1974, Vol. 4 Issue 5946, p697
Academic Journal
No abstract available.


Related Articles

  • Mechanisms in the development of analgesic nephropathy. Duggin, Geoffrey G. // Kidney International;Nov1980, Vol. 18 Issue 5, p553 

    Studies the mechanisms in the development of analgesic nephropathy. Renal excretory mechanisms of analgesics; Hypotheses for pathophysiologic mechanism; Intrarenal distribution of analgesics; Metabolism of analgesics within the kidney.

  • dantron. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p212 

    An encyclopedia entry for "dantron" is presented. It refers to a stimulant laxative drug that is used to treat constipation among terminally ill patients, which is said to be caused by treatment with opioid analgesic drugs. Noted is the possibility that the intake of dantron will make the urine...

  • Warfarin.  // Reactions Weekly;Jun2015, Vol. 1554 Issue 1, p194 

    An abstract of the article "Warfarin-related nephropathy: Possible role for the warfarin pharmacogenetic profile," by V. Di Maso and colleagues is presented.

  • Relevance of animal models to analgesic-associated renal papillary necrosis in humans. Bach, Peter H.; Hardy, T. L. // Kidney International;Oct1985, Vol. 28 Issue 4, p605 

    Discusses the relevance of animal models to analgesic-associated renal papillary necrosis (RPN) in humans. Role of excessive analgesic consumption as a very important contributing factor in the development of chronic renal disease, an expensive health care problem; Development and course of...

  • Nutrient Sensing, Autophagy, and Diabetic Nephropathy. Kume, Shinji; Thomas, Merlin C.; Koya, Daisuke // Diabetes;Jan2012, Vol. 61 Issue 1, p23 

    The article explains the possible use of nutrient-sensing pathways as a therapeutic target for diabetic nephropathy. It explains the physiological mechanisms of nutrient sensing, the process of autophagy, and diabetic nephropathy. Particular focus is given to the role of mammalian target of...

  • Relationship between nonphenacetin combined analgesics and nephropathy. Bennett, William M. // Kidney International;Nov2001, Vol. 60 Issue 5, p2039 

    Presents a correspondence on the relationship between analgesics and nephropathy. Debate on the existence of analgesic nephropathy; Invitation for readers to know the relationship between the German Medicines Manufacturers Association and the study; Insufficiency of the two-day meeting a...

  • Reply from the author. Feinstein, Alvan R.; Heinemann, Lothar A.J. // Kidney International;Nov2001, Vol. 60 Issue 5, p2039 

    Comments on the correspondence concerning analgesics and nephropathy. Finance on the research of the committee by the pharmaceutical industry; selection of committee members by the industry and regulatory authorities; Clarification on the focus of the research on analgesic nephropathy and the...

  • Antacids and laxatives don't mix with other medications.  // Consumer Reports on Health;May92, Vol. 4 Issue 5, p38 

    Looks at possible medication interactions if you take antacids or laxatives within hours of other medications. Interactions between laxatives and anticoagulants; Antacids and phenothiazines for psychiatric disorders; Antacids and Dilantin; Laxatives and tetracycline; More.

  • Renal papillary necrosis after aspirin and alclofenac. Gokal, R.; Matthews, D.R. // British Medical Journal;12/10/1977, Vol. 2 Issue 6101, p1517 

    Examines the association between renal papillary necrosis and long-term analgesic consumption. Determination of toxic components of phenacetin; Etiology of analgesic nephropathy; Components of alclofenac.

  • Non-phenacetin analgesics and analgesic nephropathy: Clinical assessment of high users from a case-control study [1]*. Paul Michielsen; Lothar Heinemann; Michael Mihatsch; Peter Schnülle; Helmut Graf; Karl-Martin Koch // Nephrology Dialysis Transplantation;Apr2009, Vol. 24 Issue 4, p1253 

    Background. A recent large-scale case-control study on analgesic nephropathy (SAN) [1] found no increased risk of end-stage renal disease (ESRD) in users of combined or single formulations of phenacetin-free analgesics. In a subgroup of 22 high users, however, a dose-dependent increased risk was...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics